Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 7 studies | 34% ± 22% | |
| epithelial cell | 7 studies | 27% ± 9% | |
| GABAergic neuron | 6 studies | 45% ± 28% | |
| astrocyte | 6 studies | 43% ± 19% | |
| endothelial cell | 6 studies | 25% ± 9% | |
| oligodendrocyte precursor cell | 5 studies | 44% ± 22% | |
| microglial cell | 4 studies | 33% ± 10% | |
| macrophage | 4 studies | 25% ± 8% | |
| interneuron | 4 studies | 61% ± 23% | |
| Mueller cell | 3 studies | 40% ± 25% | |
| amacrine cell | 3 studies | 30% ± 16% | |
| retinal cone cell | 3 studies | 29% ± 13% | |
| retinal rod cell | 3 studies | 26% ± 6% | |
| myeloid cell | 3 studies | 21% ± 5% | |
| fibroblast | 3 studies | 37% ± 14% | |
| pericyte | 3 studies | 41% ± 16% | |
| smooth muscle cell | 3 studies | 25% ± 5% | |
| oligodendrocyte | 3 studies | 33% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 294.41 | 1445 / 1445 | 100% | 5.52 | 183 / 183 |
| stomach | 100% | 280.14 | 359 / 359 | 98% | 3.66 | 279 / 286 |
| lung | 100% | 342.10 | 578 / 578 | 97% | 3.22 | 1125 / 1155 |
| ovary | 100% | 331.14 | 180 / 180 | 96% | 4.32 | 414 / 430 |
| thymus | 100% | 448.57 | 653 / 653 | 96% | 2.15 | 581 / 605 |
| bladder | 100% | 287.43 | 21 / 21 | 96% | 2.85 | 483 / 504 |
| intestine | 100% | 395.28 | 966 / 966 | 95% | 2.87 | 502 / 527 |
| kidney | 100% | 465.25 | 89 / 89 | 94% | 6.21 | 851 / 901 |
| prostate | 100% | 341.69 | 245 / 245 | 94% | 2.34 | 474 / 502 |
| pancreas | 100% | 228.42 | 327 / 328 | 93% | 2.22 | 165 / 178 |
| uterus | 100% | 403.74 | 170 / 170 | 90% | 2.55 | 412 / 459 |
| breast | 100% | 350.31 | 459 / 459 | 88% | 2.32 | 988 / 1118 |
| adrenal gland | 100% | 342.42 | 258 / 258 | 82% | 1.56 | 188 / 230 |
| skin | 100% | 446.58 | 1809 / 1809 | 82% | 1.73 | 385 / 472 |
| liver | 100% | 301.97 | 226 / 226 | 77% | 1.54 | 313 / 406 |
| brain | 91% | 150.24 | 2413 / 2642 | 75% | 1.22 | 529 / 705 |
| adipose | 100% | 304.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 370.19 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.12 | 1 / 1 |
| blood vessel | 100% | 280.31 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 219.12 | 800 / 803 | 0% | 0 | 0 / 0 |
| heart | 94% | 212.52 | 806 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 2.23 | 27 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 1.74 | 40 / 45 |
| peripheral blood | 79% | 310.48 | 736 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 41% | 0.64 | 33 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1904659 | Biological process | glucose transmembrane transport |
| GO_0006814 | Biological process | sodium ion transport |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0015293 | Molecular function | symporter activity |
| GO_0005355 | Molecular function | glucose transmembrane transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MFSD4B |
| Protein name | Major facilitator superfamily domain containing 4B Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B) |
| Synonyms | HSPC100 KIAA1919 NAGLT1 |
| Description | FUNCTION: May function as a sodium-dependent glucose transporter. Potential channels for urea in the inner medulla of kidney. . |
| Accessions | ENST00000671883.1 ENST00000672554.1 ENST00000673024.1 A0A5K1VW69 A0A5F9ZH60 ENST00000368847.5 ENST00000672303.1 Q5TF39 ENST00000672750.1 A0A5F9ZH20 A0A5F9ZH84 ENST00000672191.1 ENST00000671876.2 |